Back to search

France· FR:61124589

EPLERENONE ACCORD 25 mg, comprimé pelliculé

A eplerenone product containing éplérénone, registered in France by ACCORD HEALTHCARE FRANCE, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C03DA04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedEPLERENONE ACCORD 25 mg, comprimé pel…ATCC03DA04REGISTER NO.FR:61124589PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Eplerenone is registered in 17 of 19 countries.

Countries holding a registration under ATC C03DA04 (eplerenone), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Eplerenone · ATC C03DA04

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eplerenone costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $1.05 in France to $3.72 in Switzerland — a ×3.6 gap.

  • France: $1.05 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Eplerenone · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.72
  • IT Italy$1.47
  • FR France$1.05
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ÉPLÉRÉNONE
Manufacturer
ACCORD HEALTHCARE FRANCE
Country
France (FR)
ATC code
C03DA04
ATC class
Eplerenone
Defined daily dose
50 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930086483
    30 plaquette(s) PVC aluminium de 1 comprimé(s)
    EUR 13.8
  • cip13
    3400930086490
    90 plaquette(s) PVC aluminium de 1 comprimé(s)
    EUR 38.56

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

230 interactions on record for eplerenone.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Eplerenone · interactions on record

230 records

  • 32 severe
  • 97 moderate
  • 3 minor
  • 24 info

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • AprepitantA04AD12severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe

74 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eplerenone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eplerenone products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Eplerenon +pharma, Eplerenon Actavis
  • Belgium · Eplerenone Ab, Inspra
  • Bulgaria · Eспиро, Аплериа
  • Cyprus · Apleria, Eplerenone Accord
  • Czechia · Apleria, Eplerenon Medreg
  • Germany · Epleraxiro, Eplerenon 1 A Pharma
  • Denmark · Eplerathen, Eplerenon Accord
  • Estonia · Apleria
  • Spain · Elecor, Eplerenona Alter
  • Finland · Inspra
  • United Kingdom (Northern Ireland) · Eplerenone, Eplerenone Accord Healthcare
  • Greece · Apleria, Eleveon
  • Croatia · Apleria, Diuron
  • Hungary · Diupot, Eplerenon Krka
  • Ireland · Eplerenone Accord Healthcare, Eplerenone Krka
  • Iceland · Eplerenon Bluefish, Eplerenon Krka
  • Italy · Eplerenone Accord, Eplerenone Doc Generici
  • Lithuania · Apleria
  • Luxembourg · Inspra
  • Latvia · Enplerasa, Plecard
  • Netherlands · Eplerenon Accord, Eplerenon Amarox
  • Norway · Eplerenon Accord, Eplerenon Krka
  • Poland · Eleveon, Enplerasa
  • Portugal · Eplerenona Biofarmoz, Eplerenona Blovasc
  • Romania · Apleria, Eplerenonă Arena
  • Sweden · Eplerenon Accord, Eplerenon Bluefish
  • Slovenia · Elreptic, Enplerasa
  • Slovakia · Aldepla, Apleria

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/31d30226-7ec1-4266-a1ae-0d63f217939d
GET /v1/drugs/31d30226-7ec1-4266-a1ae-0d63f217939d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61124589",
  "date_amm": "2017-09-14",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "ÉPLÉRÉNONE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about eplerenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.